Keiko Murase
Nishinomiya-hama, 6638501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy.
Journal: Breast cancer (Tokyo, Japan)
Published: November 04, 2024
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.
Journal: International journal of clinical oncology
Published: July 14, 2024
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors.
Journal: Anticancer research
Published: July 24, 2022
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Journal: World journal of surgical oncology
Published: June 17, 2017
Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes.
Journal: Breast (Edinburgh, Scotland)
Published: April 12, 2016
Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.
Journal: Breast cancer (Tokyo, Japan)
Published: November 26, 2015
High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.
Journal: Breast cancer research and treatment
Published: September 19, 2015
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.
Journal: International journal of clinical oncology
Published: February 16, 2015
Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
Journal: Clinical breast cancer
Published: September 29, 2014
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Journal: Clinical breast cancer
Published: September 26, 2014
Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.
Journal: Breast cancer (Tokyo, Japan)
Published: March 03, 2014
Last Updated: 09/26/2026